Načítá se...
Targeting pathological B cell receptor signalling in lymphoid malignancies
Signalling through the B cell receptor (BCR) is central to the development and maintenance of B cells. In light of the numerous proliferative and survival pathways activated downstream of the BCR, it comes as no surprise that malignant B cells would co-opt this receptor to promote their own growth a...
Uloženo v:
| Vydáno v: | Nat Rev Drug Discov |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7595252/ https://ncbi.nlm.nih.gov/pubmed/23449308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrd3937 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|